Regenerative Medicine Solutions
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Regenerative Medicine Solutions
Jun 20, 2024, 01:53 |
Insight
Miguel Bronchud: ESMO recommends performing tumour NGS to detect tumour-agnostic alterations in patients with metastatic cancers
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: “2024- ESMO of course recommends…
May 27, 2024, 13:01 |
Blog
Miguel Bronchud: Stress and cancer are they really related?
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: ''Stress and cancer- are they…
May 23, 2024, 14:58 |
Insight
Miguel Bronchud on pancreatic intraepithelial neoplasias
Miguel Bronchud, Co-Founder and Advisory Board at Regenerative Medicine Solutions, shared on LinkedIn: "Why don’t…
May 23, 2024, 13:08 |
Blog
Miguel Bronchud: Too many different treatments options for some cancer patients? Or not enough?
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: “Too many different treatments options…
May 20, 2024, 14:10 |
Insight
Miguel Bronchud: A UK large study has discovered multiple associations between blood proteins and cancer risk
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: "Hope for better selecting individuals…
All:
5
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube